Michael D. Popielec - 20 Oct 2021 Form 4 Insider Report for ULTRALIFE CORP (ULBI)

Role
Director, President and CEO, Director
Signature
/s/ Michael D. Popielec
Issuer symbol
ULBI
Transactions as of
20 Oct 2021
Net transactions value
$0
Form type
4
Filing time
22 Oct 2021, 11:06:24 UTC
Previous filing
12 Aug 2021
Next filing
21 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ULBI Common Stock; $.10 par value 309,926 20 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ULBI Common Stock (Right to Buy) Award $0 +40,000 $0.000000 40,000 20 Oct 2021 Common Stock 40,000 $6.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as follows: 13,334 shares on 10-20-2022; 13,333 shares vest on 10-20-2023 and 13,333 shares vest on 10-20-2024.